J1164 HCPCS Level II code: Injection, diltiazem hydrochloride in 0.72% sodium chloride, 0.5 mg

J1164 is the HCPCS code for “Injection, diltiazem hydrochloride in 0.72% sodium chloride, 0.5 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.

Official description

J1164

Injection, diltiazem hydrochloride in 0.72% sodium chloride, 0.5 mg

Short description: Inj diltiazem in 0.72% nacl

HCPCS · United States

Medicare details

The indicators CMS publishes with J1164 in its October 2026 file. They describe Medicare’s handling, not another payer’s.

Medicare coverage
Carrier judgment
Medicare pricing
Drugs
Type of service
Medical care; Lump sum purchase of DME, prosthetics, orthotics
BETOS category
Other drugs
Added
Apr 1, 2026

Where J1164 sits

  1. 1J codesDrugs administered other than orally
  2. 2Active code J1164Injection, diltiazem hydrochloride in 0.72% sodium chloride, 0.5 mg

Source and release

Data release
HCPCS Level II · October 2026
Effective date
Oct 1, 2026
Publisher
CMS

This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.

Frequently asked questions

What does HCPCS code J1164 mean?

J1164 is the HCPCS code for “Injection, diltiazem hydrochloride in 0.72% sodium chloride, 0.5 mg” in CMS’s HCPCS Level II October 2026 release.

Does Medicare cover J1164?

CMS lists J1164’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.

Which HCPCS Level II release does this page use?

It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.